Authors:
Simsir, A
Fetsch, P
Bedrossian, CWM
Ioffe, OB
Abati, A
Citation: A. Simsir et al., Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: An immunocytochemical study, DIAGN CYTOP, 25(4), 2001, pp. 203-207
Citation: Pa. Fetsch et al., Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology, DIAGN CYTOP, 25(3), 2001, pp. 158-161
Authors:
Fetsch, PA
Filie, AC
Steinberg, SM
Abati, A
Citation: Pa. Fetsch et al., Comparison of antibodies to MART-1 and MelanA in fine-needle aspiration samples of metastatic malignant melanoma, DIAGN CYTOP, 25(1), 2001, pp. 78-79
Authors:
Simsir, A
Palacios, D
Linehan, WM
Merino, MJ
Abati, A
Citation: A. Simsir et al., Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: Utilization of microdissection and polymerase chain reaction in archival tissues, DIAGN CYTOP, 24(5), 2001, pp. 328-332
Authors:
Braga, D
Abati, A
Scaccianoce, L
Johnson, BFG
Grepioni, F
Citation: D. Braga et al., Organometallic polymorphism. Synthesis and structural characterization of two forms of [Ru(eta(6)-C6H6)(eta(6)-C6H4(CH3)COOCH3)][BF4](2) and the phase transition in [Ru(eta(5)-C5H5)(eta(6) -C6H5OH)][PF6], SOLID ST SC, 3(7), 2001, pp. 783-788
Authors:
Fetsch, PA
Cowan, KH
Weng, DE
Freifield, A
Filie, AC
Abati, A
Citation: Pa. Fetsch et al., Detection of circulating tumor cells and micrometastases in stage II, III,and IV breast cancer patients utilizing cytology and immunocytochemistry, DIAGN CYTOP, 22(5), 2000, pp. 323-328
Authors:
Filie, AC
Copeland, C
Wilder, AM
Abati, A
Citation: Ac. Filie et al., Individual specimen triage of effusion samples: An improvement in the standard of practice, or a waste of resources?, DIAGN CYTOP, 22(1), 2000, pp. 7-10
Authors:
Litman, T
Brangi, M
Hudson, E
Fetsch, P
Abati, A
Ross, DD
Miyake, K
Resau, JH
Bates, SE
Citation: T. Litman et al., The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2), J CELL SCI, 113(11), 2000, pp. 2011-2021
Citation: Pa. Fetsch et al., Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?, DIAGN CYTOP, 20(6), 1999, pp. 393-396
Authors:
Simsir, A
Fetsch, P
Stetler-Stevenson, M
Abati, A
Citation: A. Simsir et al., Immunophenotypic analysis of non-Hodgkin's lymphomas in cytologic specimens: A correlative study of immunocytochemical and flow cytometric techniques, DIAGN CYTOP, 20(5), 1999, pp. 278-284
Citation: Pa. Fetsch et al., Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?, DIAGN CYTOP, 20(4), 1999, pp. 249-252
Authors:
Simsir, A
Fetsch, P
Mehta, D
Zakowski, M
Abati, A
Citation: A. Simsir et al., E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, thebad, the worthless, DIAGN CYTOP, 20(3), 1999, pp. 125-130
Authors:
Nagaraju, K
Raben, N
Villalba, ML
Danning, C
Loeffler, LA
Lee, E
Tresser, N
Abati, A
Fetsch, P
Plotz, PH
Citation: K. Nagaraju et al., Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells, CLIN IMMUNO, 92(2), 1999, pp. 161-169
Authors:
Cowan, KH
Moscow, JA
Huang, H
Zujewski, JA
O'Shaughnessy, J
Sorrentino, B
Hines, K
Carter, C
Schneider, E
Cusack, G
Noone, M
Dunbar, C
Steinberg, S
Wilson, W
Goldspiel, B
Read, EJ
Leitman, SF
McDonagh, K
Chow, C
Abati, A
Chiang, Y
Chang, YN
Gottesman, MM
Pastan, I
Nienhuis, A
Citation: Kh. Cowan et al., Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing themultidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients, CLIN CANC R, 5(7), 1999, pp. 1619-1628
Authors:
Riker, AI
Panelli, MC
Kammula, US
Wang, E
Wunderlich, J
Abati, A
Fetsch, P
Rosenberg, SA
Marincola, FM
Citation: Ai. Riker et al., Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma, CANCER DET, 23(5), 1999, pp. 387-396